Eton Pharmaceuticals (ETON) Gross Margin (2019 - 2025)
Historic Gross Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 34.97%.
- Eton Pharmaceuticals' Gross Margin fell 260700.0% to 34.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 65.88%, marking a year-over-year increase of 299100.0%. This contributed to the annual value of 60.01% for FY2024, which is 65500.0% down from last year.
- Eton Pharmaceuticals' Gross Margin amounted to 34.97% in Q3 2025, which was down 260700.0% from 63.0% recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Gross Margin registered a high of 552.13% during Q1 2025, and its lowest value of 12.18% during Q4 2023.
- For the 5-year period, Eton Pharmaceuticals' Gross Margin averaged around 89.02%, with its median value being 62.85% (2024).
- As far as peak fluctuations go, Eton Pharmaceuticals' Gross Margin plummeted by -72061100bps in 2021, and later skyrocketed by 4892700bps in 2025.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Gross Margin stood at 93.89% in 2021, then fell by -20bps to 74.84% in 2022, then tumbled by -84bps to 12.18% in 2023, then surged by 356bps to 55.6% in 2024, then plummeted by -37bps to 34.97% in 2025.
- Its Gross Margin was 34.97% in Q3 2025, compared to 63.0% in Q2 2025 and 552.13% in Q1 2025.